Literature DB >> 17223759

Epidemiologic assessment of porcine circovirus type 2 coinfection with other pathogens in swine.

Paul M Dorr1, Rodney B Baker, Glen W Almond, Spencer R Wayne, Wondwossen A Gebreyes.   

Abstract

OBJECTIVE: To identify important pathogens and characterize their serologic and pathologic effects in porcine circovirus type 2 (PCV2)-infected pigs in relation to pig age and type of swine production system.
DESIGN: Cross-sectional study. ANIMALS: 583 conventionally reared pigs. PROCEDURES: 3- (n = 157), 9- (149), 16- (152), and 24-week-old (125) pigs from 41 different 1-, 2-, and 3-site production systems (5 pigs/age group/farm) were euthanized and necropsied. Pigs with and without PCV2 infection were identified (via PCR assay); infection with and serologic responses to other pathogens and pathologic changes in various tissues (including lungs) were assessed. Logistic regression models were constructed for effects overall and within each age group and type of production system.
RESULTS: Compared with PCV2-negative pigs, PCV2-positive pigs were more likely to have swine influenza virus (SIV) type A and Mycoplasma hyopneumoniae infections and sample-to-positive (S:P) ratios for SIV H1N1 from 0.50 to 0.99; also, PCV2-positive pigs had higher serum anti-porcine reproductive and respiratory syndrome virus (PRRSV) antibody titers and more severe lung tissue damage. Infection with SIV (but lower SIV H1N1 S:P ratio) was more likely in 3-week-old PCV2-positive pigs and evidence of systemic disease was greater in 16-week-old PCV2-positive pigs than in their PCV2-negative counterparts. By site type, associations of coinfections and disease effects between PCV2-positive and -negative pigs were greatest in 3-site production systems. CONCLUSIONS AND CLINICAL RELEVANCE: In PCV2-positive pigs, coinfections with SIV, M. hyopneumoniae, and PRRSV are important, having the greatest effect in the early to late nursery phase and in 3-site production systems.

Entities:  

Mesh:

Year:  2007        PMID: 17223759     DOI: 10.2460/javma.230.2.244

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  24 in total

1.  Porcine reproductive and respiratory syndrome virus infection at the time of porcine circovirus type 2 vaccination has no impact on vaccine efficacy.

Authors:  A Sinha; H G Shen; S Schalk; N M Beach; Y W Huang; P G Halbur; X J Meng; T Opriessnig
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Genomic analysis of porcine circovirus type-2 isolates in Alberta pigs demonstrating clinical porcine circovirus associated disease (PCVAD).

Authors:  Leila McIntyre; Mark Chaiyakul; Edward G Clark; Frank Marshall; Markus Czub
Journal:  Can J Vet Res       Date:  2010-04       Impact factor: 1.310

3.  Characterization of a new disease syndrome associated with porcine circovirus type 2 in previously vaccinated herds.

Authors:  Ada G Cino-Ozuna; Steven Henry; Richard Hesse; Jerome C Nietfeld; Jianfa Bai; H Morgan Scott; Raymond R R Rowland
Journal:  J Clin Microbiol       Date:  2011-02-23       Impact factor: 5.948

4.  Porcine circovirus genotypes and their copathogens in pigs with respiratory disease in southern provinces of Vietnam.

Authors:  Phat Xuan Dinh; Minh Nam Nguyen; Hien The Nguyen; Vu Hoang Tran; Quy Dinh Tran; Kim Hoang Dang; Dai Tan Vo; Hien Thanh Le; Nam Thi Thu Nguyen; Toan Tat Nguyen; Duy Tien Do
Journal:  Arch Virol       Date:  2021-01-03       Impact factor: 2.574

5.  Infection of cesarean-derived colostrum-deprived pigs with porcine circovirus type 2 and Swine influenza virus.

Authors:  Huiling Wei; Stephen D Lenz; William G Van Alstine; Gregory W Stevenson; Ingeborg M Langohr; Roman M Pogranichniy
Journal:  Comp Med       Date:  2010-02       Impact factor: 0.982

6.  Antibody recognition of porcine circovirus type 2 capsid protein epitopes after vaccination, infection, and disease.

Authors:  Benjamin R Trible; Maureen Kerrigan; Nicholas Crossland; Megan Potter; Kay Faaberg; Richard Hesse; Raymond R R Rowland
Journal:  Clin Vaccine Immunol       Date:  2011-03-23

7.  The effect of vaccination against Porcine reproductive and respiratory syndrome virus (PRRSV) on the Porcine circovirus-2 (PCV-2) load in porcine circovirus associated disease (PCVAD) affected pigs.

Authors:  Marika Genzow; Kent Schwartz; Glenda Gonzalez; Gail Anderson; Wayne Chittick
Journal:  Can J Vet Res       Date:  2009-04       Impact factor: 1.310

8.  Quantitative polymerase chain reaction for Porcine circovirus-2 in swine feces in a Porcine circovirus disease-affected commercial herd and a nonaffected commercial herd.

Authors:  Kathleen A McIntosh; John C S Harding; Sarah Parker; Steven Krakowka; Gordon Allan; John A Ellis
Journal:  Can Vet J       Date:  2008-12       Impact factor: 1.008

9.  Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2.

Authors:  Peiyang Ding; Qianyue Jin; Xinxin Chen; Suzhen Yang; Junqing Guo; Guangxu Xing; Ruiguang Deng; Aiping Wang; Gaiping Zhang
Journal:  Int J Nanomedicine       Date:  2019-09-16

10.  Economic efficiency analysis of different strategies to control post-weaning multi-systemic wasting syndrome and porcine circovirus type 2 subclinical infection in 3-weekly batch system farms.

Authors:  Pablo Alarcon; Jonathan Rushton; Heiko Nathues; Barbara Wieland
Journal:  Prev Vet Med       Date:  2013-02-01       Impact factor: 2.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.